Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 11/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.60 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23646225 | 1.00 | EPHX1 (0.69) | EPHX1EPHX2PRMT1ALOX5 | |
| SCHEMBL23646204 | 1.00 | EPHX1 (0.69) | EPHX1EPHX2PRMT1ALOX5 | |
| SCHEMBL23646256 | 1.00 | EPHX1 (0.69) | EPHX1EPHX2PRMT1ALOX5 | |
| SCHEMBL1065387 | 0.82 | EPHX1 (1.00) | EPHX1EPHX2 | |
| SCHEMBL1066578 | 0.82 | EPHX1 (1.00) | EPHX1EPHX2 | |
| SCHEMBL15741883 | 0.82 | EPHX1 (1.00) | EPHX1EPHX2 | |
| SCHEMBL28612121 | 0.82 | EPHX1 (1.00) | EPHX1EPHX2 | |
| SCHEMBL4009806 | 0.81 | EPHX1 (0.46) | EPHX1EPHX2 | |
| SCHEMBL23646186 | 0.79 | EPHX1 (0.73) | EPHX1EPHX2PRMT1 | |
| SCHEMBL23646241 | 0.79 | EPHX1 (0.73) | EPHX1EPHX2PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12258324-B2 | Fatty acid analogues and methods of use | LIN BIOSCIENCE INC. (TW) | 2025-03-25 | — | — | US | disclosed |
| US-20210221781-A1 | FATTY ACID ANALOGUES AND METHODS OF USE | LIN BIOSCIENCE INC. (TW) | 2021-07-22 | — | — | US | disclosed |
| US-20210221781-A1 | FATTY ACID ANALOGUES AND METHODS OF USE | LIN BIOSCIENCE INC. (TW) | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210221781-A1 | FATTY ACID ANALOGUES AND METHODS OF USE | ELOVL1, FADS1, ALOX5 | EPHX1 1873/4885EPHX2 2379/4885PRMT1 4275/4885 |
| US-12258324-B2 | Fatty acid analogues and methods of use | ELOVL1, FADS1, ALOX5 | EPHX1 1873/4885EPHX2 2379/4885PRMT1 4275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.